A new study found that part of the Epstein-Barr virus mimics a protein made in the ... was further assessed by using a common ...

Epstein–Barr virus (EBV) infection is implicated in the aetiology of several different lymphoid and epithelial malignancies. EBV-encoded latent genes induce B-cell transformation in vitro by ...

Sixty years after the discovery of the Epstein–Barr virus (EBV), Münz discusses new ... the authors developed a new 3D human neurovascular unit (NVU) model in vitro that allows to probe the ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

The biggest challenge was finding a large enough EBV-negative population, given the virus’s high prevalence. In 2000, he partnered with the US military and used samples from the Department of ...